Beryl Drugs has scheduled its 33rd Annual General Meeting (AGM) for September 29, 2026. The board approved the notice and finalized remote e-voting logistics during its September 2 meeting.

The session also authorized an increase in the limit for material related-party transactions with Aminova Infusions Pvt. Ltd., signaling expanded operational collaboration between the entities.

E-Voting Schedule

Pursuant to Regulation 44 of the SEBI (LODR) Regulations, 2015 and Section 108 of the Companies Act, 2013, the company will provide remote e-voting facilities through CDSL. The cut-off date for e-voting entitlement is September 22, 2026.

Meeting Outcome Details

The board meeting, held at the registered office in Indore, began at 2:00 pm and concluded at 5:00 pm. Directors addressed statutory matters required for the upcoming AGM, including fixing the date and approving the notice.

Key procedural approvals included:

• Fixing the cut-off date and remote e-voting period for the 33rd AGM
• Determining the annual book closure period
• Appointing Dipika Kataria as the scrutinizer for remote e-voting and voting at the AGM
• Authorizing directors to authenticate and file necessary forms under the Companies Act, 2013

The board also considered any other resolutions with the permission of the chair.

Corporate Governance Update

The outcome was communicated by Sudhir Sethi, Chairman & Director. The disclosure was directed to the Secretary of The Bombay Stock Exchange Limited, ensuring compliance with regulatory norms.

The approval of increased transaction limits with Aminova Infusions Pvt. Ltd. is subject to further shareholder oversight at the forthcoming AGM.

Beryl Drugs Limited disclosed on August 19, 2026, that its promoter, Sudhir Sethi, acquired 4809 equity shares in the company. The acquisition took place on August 18, 2026, through market transactions.

The purchase increased Sethi’s total holding to 518,928 shares, representing a 10.24% stake in the company’s total voting capital. Prior to this transaction, he held 514,119 shares, constituting 10.14% of the equity.

Acquisition Details

The company filed the disclosure with the stock exchanges under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The total equity share capital of the target company remained unchanged at 5,071,700 shares before and after the acquisition.

What the Numbers Show

The acquisition reflects a marginal increase in promoter ownership via open market purchases rather than off-market transfers or preferential allotments. With the promoter group maintaining a consolidated voting power above 10%, the move reinforces existing control structures without triggering open offer obligations under current regulations.